Related Experiment Video

Updated: Jul 17, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
08:52

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant

Published on: May 27, 2011

Combination nonviral cytokine gene therapy for head and neck cancer

D Li1, J W Zeiders, S Liu

  • 1Department of Otolaryngology-Head and Neck Surgery, University of Maryland School of Medicine, 16 South Eutaw Street, Baltimore, MD 21201, USA.

The Laryngoscope
|May 23, 2001
PubMed
Abstract

Insights

Combination gene therapy using murine interferon-alpha (mIFN-alpha) with either murine interleukin-2 (mIL-2) or murine interleukin-12 (mIL-12) demonstrated significant antitumor effects in a head and neck cancer model. This approach enhanced natural killer and T-cell activity, supporting further research.

Area of Science:

  • Immunotherapy
  • Gene Therapy
  • Oncology

Background:

  • Head and neck squamous cell carcinoma (HNSCC) presents significant treatment challenges.
  • Cytokine-based gene therapy offers a potential strategy for enhancing antitumor immunity.

Purpose of the Study:

  • To evaluate the feasibility and efficacy of combined nonviral gene therapy using murine interferon-alpha (mIFN-alpha) with either murine interleukin-2 (mIL-2) or murine interleukin-12 (mIL-12) for HNSCC.
  • To assess the impact of this combination therapy on antitumor responses and immune cell activity in a murine model.

Main Methods:

  • Randomized controlled studies were conducted in a murine HNSCC model.
  • Tumors were treated with polymer- or lipid-formulated mIFN-alpha, mIL-2, or mIL-12, alone or in combination.
  • Antitumor responses, cytokine expression, natural killer (NK) cell activity, and cytolytic T-cell (CTL) activity were measured.

Main Results:

  • Combination therapy of mIFN-alpha with either mIL-2 or mIL-12 yielded significant antitumor effects compared to single-agent therapies and controls (P = .002).
  • Increased NK cell activity and CD8+ cytotoxic T-lymphocyte (CTL) activity were observed in combination treatment groups.
  • Augmented immune responses correlated with observed clinical antitumor effects.

Conclusions:

  • Murine interleukin-2 (mIL-2) or murine interleukin-12 (mIL-12) gene therapy augments the tumor-inhibitory effects of murine interferon-alpha (mIFN-alpha).
  • Combination therapy enhances the activation of NK cells and CD8+ T cells.
  • These findings support further investigation into polymer- and lipid-mediated delivery of cytokine genes for HNSCC treatment.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on: February 21, 2025

Related Concept Videos

Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.